ReviewTranslational psychiatry2026
The nature of depression and the biomedical model: ten questions in search of an answer.
Review in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New quality productivity-driven development of clinical nutrition in Chinese public hospitals: a Chongqing survey.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papers that dispute the neurobiological basis of depression and the usefulness of antidepressants keep emerging; therefore, a thorough review is necessary to register pro and con arguments. The current paper formulated 10 questions and tried to provide evidence-based answers. Depression is not a functional stress reaction to life events; it is a dysfunction in mood, affect, and emotion regulation, which results in dysfunctional responses. The reductionism of the biomedical model has no alternative if a scientific pathway is to be followed. Psychosocial approaches find it very difficult to meet the falsification criterion, while methodological shortcomings in pharmacological trials leave room for unsubstantiated discussion of the role of non-biological factors in the response to medication. The dispute over the efficacy of antidepressants has long been resolved and the argument that antidepressants exert their efficacy through a generic emotional numbness was rejected. Psychotherapies probably act through a generic pathway, including simple, practical interventions and relationship compassion. Inevitably, the advances promised by neurosciences, biological psychiatry, and psychopharmacology will eventually pave the way for better outcomes. A profound culture change is essential to ensure that our field is ready to embrace new findings as they emerge. However, a strong psychosocial element and psychoeducation techniques will probably be of prime importance in the future; patients and their families need education and persuasion, otherwise any scientific breakthrough would have little effect on their lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.